Inulin in Burn-induced Insulin Resistance

Launched by UNIVERSITY OF BELGRADE · Sep 4, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how a dietary supplement called inulin might help people who have developed insulin resistance after suffering from burn injuries. Insulin resistance is when the body doesn't use insulin effectively, which can happen after significant burns. The researchers want to see if taking inulin can reduce this issue and improve health outcomes for patients.

To participate in this study, you need to be at least 18 years old and have experienced burns that required hospital treatment. You also need to have insulin resistance, which will be checked on the fifth day of your hospital stay. However, certain conditions like pre-existing insulin resistance, diabetes, or being pregnant will exclude you from joining. If you decide to take part, you will be contributing to important research that could help improve care for burn patients in the future. The trial is not yet recruiting participants, but it will soon be looking for volunteers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed consent and willingness in study participation
• • The age of the respondent greater than or equal to 18 years at the time of signing the informed consent
• • Burns requiring in-hospital treatment
• • insulin resistance detected on the fifth day of admission to the hospital
• Exclusion Criteria:
• • Documented pre-existing insulin resistance
• • PCOS
• • BMI ≥ 30 kg/m2
• • Pregnancy
• • Diabetes type 1
• • Diabetes type 2
• • Metabolic syndrome
• • Use of drugs that can affect insulin resistance
• • Weight loss greater than 10% in the last 6 months